Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study (Q33401346)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study |
scientific article |
Statements
1 reference
Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study (English)
1 reference
Barbara Pro
1 reference
Joseph M Connors
1 reference
Michelle Fanale
1 reference
Ranjana Advani
1 reference
Nancy L Bartlett
1 reference
Pauline Brice
1 reference
Joseph D Rosenblatt
1 reference
Jeffrey Matous
1 reference
Radhakrishnan Ramchandren
1 reference
Yin Yang
1 reference
Eric L Sievers
1 reference
Dana A Kennedy
1 reference
Andrei Shustov
1 reference
21 May 2012
1 reference
1 reference
30
1 reference
18
1 reference
2190-2196
1 reference
Identifiers
1 reference
1 reference